At the same time, some endoscopic interventions have associated bleeding risks that are increased by the anticoagulant administered for thromboembolism. The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. Management of anticoagulation in patients undergoing endoscopic procedures is challenging because interrupting anticoagulation for a procedure transiently increases the risk of thromboembolism. The cookie is used to store the user consent for the cookies in the category 'Performance'. This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category 'Other.

The cookies is used to store the user consent for the cookies in the category 'Necessary'. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category 'Functional'.

The cookie is used to store the user consent for the cookies in the category 'Analytics'. These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly.

International Horizon Scanning Initiative.

Template, Registration form, Guidelines and Tip Sheet.

Overview of the Drug Reimbursement Process.

Praxbind binds to dabigatran and its metabolites more strongly than the binding affinity of dabigatran to thrombin, neutralizing the anticoagulant effect. Praxbind is an intravenous humanized monoclonal antibody fragment (Fab) that binds to Pradaxa (dabigatran) to neutralize its effect and control bleeding. Andexxa and Praxbind are both used to treat life-threatening or uncontrolled bleeding specifically due to certain anticoagulation agents, however they have different modes of action.Īndexxa (coagulation factor Xa, inactivated-zhzo) is a recombinant modified human Factor Xa (FXa) protein intravenous injection, and the first drug approved to be used for reversal of anticoagulation for serious bleeding in patients treated with the Factor Xa inhibitors rivaroxaban (Xarelto) or apixaban (Eliquis).